Fisher & Paykel HealthcareASX:FPH +0.13%88 Quick Ratio is 1.66 as of Mar. 2026, which is 11% above its 10-year median of 1.50. GuruFocus rates ASX:FPH with a GF Score™ of 88/100 and a GF Value™ of A$36.31 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Fisher & Paykel Healthcare ranks worse than 55.5% on this metric.
Fisher & Paykel Healthcare has a quick ratio of 1.66. It generally indicates good short-term financial strength.
The historical rank and industry rank for Fisher & Paykel Healthcare's Quick Ratio or its related term are showing as below:
ASX:FPH'
s Quick Ratio Range Over the Past 10 Years
Min: 1 Med: 1.5 Max: 1.74
Current: 1.66
During the past 13 years, Fisher & Paykel Healthcare's highest Quick Ratio was 1.74. The lowest was 1.00. And the median was 1.50.
ASX:FPH's Quick Ratio is ranked worse than 55.5% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs ASX:FPH: 1.66
Fisher & Paykel Healthcare (ASX:FPH) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Fisher & Paykel Healthcare Quick Ratio Related Terms
Fisher & Paykel Healthcare Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:FPH vs ISRG, BDX, MDLN: Quick Ratio Comparison
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's Quick Ratio falls into.
Fisher & Paykel Healthcare Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare (ASX:FPH) has a Quick Ratio of 1.66 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Fisher & Paykel Healthcare and its competitors. This is 11% above median its historical median of 1.50. Over the past decade, Fisher & Paykel Healthcare's Quick Ratio has ranged from 1.00 to 1.74. According to the industry distribution chart, Fisher & Paykel Healthcare ranks #474 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 55.5%.
Is Fisher & Paykel Healthcare's Quick Ratio too high?
Fisher & Paykel Healthcare's current Quick Ratio of 1.66 is 11% above median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 1.74. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Fisher & Paykel Healthcare's value of 1.66 is 11% below this industry median. Based on the distribution chart, Fisher & Paykel Healthcare ranks #474 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Fisher & Paykel Healthcare has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Quick Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fisher & Paykel Healthcare ranks #474 out of 854 companies for Quick Ratio. This places Fisher & Paykel Healthcare in the lower half of its industry. The industry median Quick Ratio is 1.87. Fisher & Paykel Healthcare's value of 1.66 is 11% below this benchmark. Historically, Fisher & Paykel Healthcare's own Quick Ratio has ranged from 1.00 to 1.74 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 1.87, Fisher & Paykel Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fisher & Paykel Healthcare's current Quick Ratio of 1.66 is 11% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Fisher & Paykel Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fisher & Paykel Healthcare's current Quick Ratio is 1.66, which is 11% above median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (ASX:FPH) is currently considered Modestly Undervalued. The stock's GF Value™ is A$36.31, compared to a current price of A$31.57 — trading 13.1% below its estimated fair value. The current Quick Ratio is 1.66, which is 11% above median its 10-year median of 1.50 and 11% below the Medical Devices & Instruments industry median of 1.87. Fisher & Paykel Healthcare's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Fisher & Paykel Healthcare (ASX:FPH), the current Quick Ratio is 1.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (ASX:FPH) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of A$31.57 is trading 13.1% below its estimated GF Value™ of A$36.31.
GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:FPH:
Quick Ratio: 1.66 (11% above median its 10-year median of 1.50)
GF Value™: A$36.31 vs. price of A$31.57 (13.1% below fair value)
Industry Position: 11% below the Medical Devices & Instruments median (#474 of 854)
No single metric tells the full story. See the ASX:FPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
88GF Score
Get the complete analysis for ASX:FPH
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:FPH has been successfully added to your 
